Rusudan Agladze MD. PhD. FESC

• 2022-2023 – PCHF (postgraduate course in heart failure), University of Zurich, European Society of Cardiology;
• 2008-2012 – Full course of doctorate in medicine, Tbilisi State University;
• 2006 – 2007 – Fellowship in cardiology, Krankenhaus der Barmherzigen Schwestern Linz, Austria (training was funded by a grant from the World Heart Federation);
• 2002-2005 – Full residency course in cardiology, Medical Academy of Georgia;
  1993-2000 – Tbilisi State Medical University, Faculty of Medicine.

Professional internship.

• August 2019 (4 weeks) – Royal Brompton Hospital, London, Great Britain;
• September 2011 (4 weeks) – Wilhelminenspital, Vienna, Austria;
• June 2002 (4 weeks) – Rehabilitarionszentrum Hochegg, Austria.

• Since 2020 till now – N. Bokhua Cardiovascular Center, Head of the Cardiology Division of the Cardiopulmonary Department;
• 2011-2020 – N. Bokhua Cardiovascular Center, Deputy Head of Cardiology Department;
• Since 2016 – D. Tvildiani Medical University, Associate Professor;
• 2014-2016 – D. Tvildiani Medical University, Assistant Professor;
• 2007 – 2012 – “Cito” Medical Center, cardiologist;
• 2007 – 2011 – “Adapti”, Angiocardiological Clinic, cardiologist.

• Since 2016, D. Tvildiani Medical University, Associate Professor;
• 2014-2016 – D. Tvildiani Medical University, Assistant Professor.

• Member FESC – Fellow of the European Society of Cardiology (since 2013);
• European Examination in Basic Cardiology (EECC) – Board Member (since 2023);
• Member of the Association for Expression Studies of the European Society of Cardiology (EACVI), the Heart Failure Association  (HFA) and the Association for Acute Cardiovascular Conditions (ACVC);
• Member of the Board of the Society of Cardiologists of Georgia (since 2017);
• Chairman of Tbilisi Society of Cardiologists (2016-2019).

Participation in conferences and congresses:

• Participated in various local and international conferences and congresses.

Publications:

• Author and co-author of more than 20 scientific works.

Experience in Phase II, III, and IV clinical trials

• 2007-2023 – co-investigator of 14 multicenter, international clinical studies;
• 2016-2023 – chief researcher of 7 multicenter, international clinical trials.

Knowledge of languages:

• Georgian – native
• Russian – fluent
• English – fluent